The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Multi-institutional evaluation of sentinel lymph node (SLN) examination by one-step nucleic acid amplification (OSNA) assay in breast cancer: Performance of metastases detection and prediction of additional non-sentinel lymph node (non-SLN) involvement.
N. Sato
No relevant relationships to disclose
K. Honma
No relevant relationships to disclose
S. Noguchi
Honoraria - Sysmex
Research Funding - Sysmex
Y. Tamaki
No relevant relationships to disclose
H. Tsuda
No relevant relationships to disclose
T. Kinoshita
No relevant relationships to disclose
S. Nakamura
No relevant relationships to disclose
K. Tsugawa
No relevant relationships to disclose
K. Suzuki
No relevant relationships to disclose
M. Tsujimoto
No relevant relationships to disclose
K. Yoshidome
No relevant relationships to disclose
F. Akiyama
No relevant relationships to disclose
T. Iwase
No relevant relationships to disclose
D. Takabatake
No relevant relationships to disclose
R. Nishimura
No relevant relationships to disclose
K. Taniyama
No relevant relationships to disclose
H. Kato
No relevant relationships to disclose
S. Umemura
No relevant relationships to disclose
Y. Tokuda
No relevant relationships to disclose
T. Kamio
No relevant relationships to disclose